Skip to main content
SpringerLink
Log in

Chemie und Pharmakologie der Neuroleptika

  • Chapter
Thioxanthene

  • 33 Accesses

Zusammenfassung

Die pharmakologische Gruppe der Neuroleptika umfaßt eine Reihe von che-misch differenten Substanzen, deren gemeinsames Merkmal die antipsychotische Wirksamkeit ist. Nach der Strukturchemie können die Neuroleptika in die 6 fol-genden Gruppen aufgegliedert werden (s. a. Übersicht 1):

  • Phenothiazine,

  • Thioxanthene,

  • Dibenzepine,

  • Butyrophenone,

  • Diphenylbutylpiperidine,

  • Benzamide.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Baldessarini RJ (1980) Drugs and the treatment of Psychiatric disorders. In: Goodman LS, Gillman A (eds) The pharmacologieal basis of therapeutics, 6th. Macmillan, New York, pp 391–425

    Google Scholar 

  • Bannon MJ, Roth RH (1983) Pharmacology of mesocortical dopamine neurons. Pharmacol Rev 35: 53–68

    PubMed  CAS  Google Scholar 

  • Bischoff S, Delini-Stula A, Maitre L (1985) Blockade der Dopaminrezeptoren im Hippokampus als Indikator antipsychotischer Wirksamkeit: Korrelation zwischen neurochemischen und psychopharmakologischen Wirkungen von Neuroleptika. In: Pflug B, Foerster K, Straube E (Hrsg) Perspektiven der Schizophrenie-Forschung. Fischer, Stuttgart, S 87–103

    Google Scholar 

  • Bunney BS (1984) Antipsychotic drug effects on the electrical activity of dopaminergic neurons. Trends Neurosci 7: 212–215

    Article  CAS  Google Scholar 

  • Bürki HR (1986) Effects of fluperlapin an dopaminergic systems in rat brain. Psychopharmacology 89: 77–84

    Article  PubMed  Google Scholar 

  • Carlsson A, Lindquist M (1963) Effect of chlorpromazine or haloperidol on formation of 3-methoxytyramine and normetanephrine in mouse brain. Acta Pharmacol Toxicol 20: 140–144

    Article  CAS  Google Scholar 

  • Chiodo LA, Bunney BS (1983) Typical and atypical neuroleptics. Differential effects of chronic administration on the activity of A 9 und A 10 midbrain dopaminergic neurons. J Neurosci 3: 1607–1619

    PubMed  CAS  Google Scholar 

  • Chiodo LA, Bunney BS (1985) Possible mechanisms by which repeated Clozapine administra¬tion differently affects the activity of two subpopulations of midbrain dopamine neurons. J Neurosci 5: 2539–2544

    PubMed  CAS  Google Scholar 

  • Creese J, Burt DR, Snyder SH (1976) Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science 192: 481–483

    Article  PubMed  CAS  Google Scholar 

  • Delini-Stula A (1986) Neuroanatomical, neuropharmacological and neurobiochemical target systems for antipsychotic activity of neuroleptics. Pharmacopsychiatry 19: 134–139

    Article  PubMed  CAS  Google Scholar 

  • Farde L, Wiesel FA, Halldin C, Sedvall G (1988 a) Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs. Arch Gen Psychiatry 45: 71–76

    Google Scholar 

  • Farde L, Wiesel FA, Nordstrom AL, Sedvall G (1988b) PET examination of human Dr dopamine receptor characteristics. Psychopharmacology 96 [Suppl]: 79

    Google Scholar 

  • Glowinski G, Tassin GP, Thierry AM (1984) The mesocortico-prefrontal dopaminergic neurons. TINS 11: 415–418

    Google Scholar 

  • Goodwin GM, Metz A (1985) Neuroleptics. In: Grahame-Smith DG (ed) Psychopharmacology 2, part 1: Preclinical psychopharmacology. Elsevier, Amsterdam, pp 206–238

    Google Scholar 

  • Haracz GL (1982) The dopamine hypothesis: an overview of studies with schizophrenic patients. Schizophr Bull 8: 438–468

    PubMed  CAS  Google Scholar 

  • Hyttel J, Arndt J, Bogeso KP (1984) Antipsychotic drugs: Configurational stereoisomers. In: Smith DF (ed) CRC handbook of stereoisomers: drugs in psychopharmacology. CRC, Boca Raton/FL, pp 143–214

    Google Scholar 

  • Kämmen DP van (1979) The dopamine hypothesis of schizophrenia revisited. Psychoneuro-endocrinology 4: 37–46

    Article  Google Scholar 

  • Kebabian JW, Calne DB (1979) Multiple receptors for dopamine. Nature 277: 92–96

    Article  Google Scholar 

  • Lindvall O, Björklund A (1978) Organisation of catecholamine neurons in the rat central nervous system. In: Iversen LL, Iversen SD, Snyder SH (eds) Handbook of psychopharmacology 9. Plenum, New York, pp 139–231

    Google Scholar 

  • Ljungberg T, Ungerstedt U (1978) Classification of neuroleptic drugs according to their ability to inhibit apomorphine-induced locomotion and gnawing: evidence for two different mechanisms of action. Psychopharmacology 56: 239–247

    Article  PubMed  CAS  Google Scholar 

  • Nieuwenhuys R, Voogd J, Huizen C van (1981) The human central nervous system. A synopsis

    Google Scholar 

  • and atlas, 2nd edn. Springer, Berlin Heidelberg New York, pp 221–230

    Google Scholar 

  • Örgren SO, Hall H, Köhler C, Magnusson O, Lindbom LO, Ängeby K, Florvall L (1984) Remoxipride, a new potential antipsychotic compound with selective antidopaminergic actions in the rat brain. Eur J Pharmacol 102: 459–474

    Article  Google Scholar 

  • Peroutka SJ, Snyder SH (1980) Relationship of neuroleptic drug effects at brain dopamine, serotonin, alfa-adrenergic, and histamine receptors to clinical potency. Am J Psychiatry 137: 1518–1522

    PubMed  CAS  Google Scholar 

  • Seeman P (1981) Brain dopamine receptors. Pharmacol Rev 32: 229–313

    Google Scholar 

  • Seeman P (1986) Dopamine/neuroleptic receptors in schizophrenia. In: Burrow GD, Norman TR, Rubinstein G (eds) Handbook of studies on schizophrenia, part 2: Management and research. Elsevier, Amsterdam, pp 243–251

    Google Scholar 

  • Seeman P, Lee T, Chan-Wong M (1976) Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature 261: 717–719.

    Article  PubMed  CAS  Google Scholar 

  • Selemon LD, Goldman-Rakic PS (1985) Longitudinal topography and interdigitation of corti-costriatal protections in the rhesus monkey. J Neurosci 5: 776–794

    PubMed  CAS  Google Scholar 

  • Snyder SH (1982) Neurotransmitters and CNS disease-schizophrenia. Lancet 8305: 970–973

    Article  Google Scholar 

  • Stoof JC, Kebabian JW (1984) Two dopamine receptors: Biochemistry, physiology and pharmacology. Life Sci 35: 2281–2296

    Google Scholar 

  • Thierry AM, Tassin JP, Glowinski J (1984) Biochemical and electrophysiological studies of the mesocortical dopamine system. In: Descarries L, Reader TR, Jasper HH (eds) Monoamine innervation of cerebral cortex. Liss, New York, pp 253–261

    Google Scholar 

  • White FJ, Wang RY (1983) Differential effects of classical and atypical antipsychotic drugs on A 9 and A 10 dopamine neurons. Science 221: 1054–1057

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. G. Budde
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Psychiatrische Klinik und Poliklinik der Freien Universität Berlin, Eschenallee 3, D-1000, Berlin 19, Germany

    B. Müller-Oerlinghausen

  2. Abteilung Psychiatrie, Universitäts-Nervenklinik und Poliklinik Bonn, Sigmund-Freud-Straße 25, D-5300, Bonn-Venusberg 1, Germany

    H.-J. Möller

  3. Psychiatrische Universitätsklinik, Robert-Koch-Straße 40, D-3400, Göttingen, Germany

    E. Rüther

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Budde, G. (1990). Chemie und Pharmakologie der Neuroleptika. In: Müller-Oerlinghausen, B., Möller, HJ., Rüther, E. (eds) Thioxanthene. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-75194-3_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-75194-3_2

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-51847-1

  • Online ISBN: 978-3-642-75194-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation